Up 20% in 5 months: Is the Ramsay Health Care share price a buy?

The Ramsay share price is up nearly 12% since the start of 2019 and over 20% since October 2018. Is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For the Motley Fool Australia writing team's Top ASX Stock Picks for March, I outlined why I believe Ramsay Health Care Ltd. (ASX: RHC) is a fantastic stock to own for the long term. The Ramsay share price is up nearly 12% since the start of 2019 and over 20% since October 2018.

So, is now a good time to buy Ramsay shares?

Ramsay Healthcare Ltd. is Australia's largest private hospital manager, with over 220 hospitals and more than 60,000 staff across Australia and several other countries. Ramsay has been expanding its presence in Europe in particular, which, due to the rapidly ageing population, is becoming a highly lucrative market.

Ramsay has historically enjoyed strong returns on invested capital due to its ownership and operation of leading private hospitals in Australia and with these, a reputation for high-quality care. Its scale also enables them to negotiate very effectively with private health insurers, which gives it enormous pricing power. This has enabled Ramsay to establish a significant cost advantage, which has underpinned its successful expansion both in Australia and overseas.

Ramsay has been facing some difficult structural problems going into 2019. Analysts were expecting core EPS growth of only 2% for the financial year, mainly due to some recent acquisitions that have yet to prove profitable for the company. The recent gains in share price were partly the result of Ramsay exceeding these expectations in its half-year results, with a 9.6% rise in profits to $270.4 million.

The sharp rise in Ramsay's share price proves the merit of taking a longer-term view than the market sometimes takes. Demographics are a tailwind for healthcare stocks like Ramsay. Our ageing population (and across the developed world) and the subsequent rising demand for medical services bodes well for the healthcare sector, which has been one of the strongest performers on the ASX over the past decade. Stocks such as CSL Limited (ASX: CSL) and NIB Holdings Limited (ASX: NHF) as well as Ramsay have delivered above-market returns to investors willing to take this long-term approach.

Foolish takeaway

I believe investing in the healthcare sector is a vital part of a 21st-century portfolio. With quality stocks like Ramsay Health Care, I would put them on my watchlist and wait for a decent buying opportunity, like we saw recently in October. No one will deny the demand for medical services will continue to rise, and this will reward the patient investor.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »